Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Allergic Reactions: Anaphylaxis

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

Allergic Reactions

Allergic Reactions

Allergic Drug Reactions

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Cross-reactivity

Cross-reactivity

Hypersensitivities

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The state of the academic medical center in allergy/immunology: Work Group Report of the AAAAI A/I Division Directors Committee.

The Journal of allergy and clinical immunology·2025

Same author

WAO - ARIA consensus on chronic cough: Executive summary.

The World Allergy Organization journal·2025

Same author

New insights in hidden food allergies.

Journal of food allergy·2024

Same author

Not all marketed skin cleansers' pH is optimal for atopic dermatitis.

Allergy and asthma proceedings·2024

Same author

Where is academic medicine going?: Part 2. Academic career and patient care.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024

Same author

Where is academic medicine going?: Part 1. Medical education and research.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2024

Search research articles

Related Experiment Video

Updated: May 24, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Not all shellfish "allergy" is allergy!

Chee K Woo¹, Sami L Bahna

¹Allergy and Immunology Section, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA. sbahna@lsuhsc.edu.

Clinical and Translational Allergy

|March 14, 2012

Summary

This summary is machine-generated.

Shellfish allergy affects 0.5-2.5% of people, with tropomyosin as the main allergen causing cross-reactivity. Diagnosis involves medical history, tests, and oral challenges, while management focuses on strict avoidance and epinephrine availability.

More Related Videos

Basophil Activation Test for Allergy Diagnosis

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Related Experiment Videos

Last Updated: May 24, 2026

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Application of Biochip Microfluidic Technology to Detect Serum Allergen-specific Immunoglobulin E (sIgE)

Published on: April 21, 2019

Basophil Activation Test for Allergy Diagnosis

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Area of Science:

Food Allergy Research
Immunology
Toxicology

Background:

Global shellfish consumption is rising, leading to increased allergic and toxic reactions.
Shellfish allergy prevalence ranges from 0.5-2.5%, varying by region and age.
Reactions to shellfish are often more severe than other food allergies.

Purpose of the Study:

To review the prevalence, allergens, diagnosis, and management of shellfish allergy.
To highlight tropomyosin as the primary allergen responsible for cross-reactivity.
To discuss challenges in diagnosis and the need for effective management strategies.

Main Methods:

Literature review of shellfish allergy studies.
Analysis of diagnostic approaches including medical history, skin testing, IgE levels, and oral challenges.
Examination of current management strategies, including avoidance and emergency treatment.

Main Results:

Tropomyosin is the major allergen in shellfish, particularly crustaceans, causing cross-reactivity.
Discrepancies between in vitro and clinical cross-allergenicity may stem from new allergens or tropomyosin structural variations.
Diagnosis relies on a combination of clinical history and objective testing, with oral challenges confirming diagnosis unless a severe reaction occurred.

Conclusions:

Strict avoidance and readily available epinephrine are key to managing shellfish allergy.
Current management does not include specific immunotherapy, necessitating further research for safe and effective protocols.
Understanding allergen structures and cross-reactivity is crucial for improving diagnosis and treatment of shellfish allergy.